抑制剂 拮抗剂 激动剂 化合物库 天然产物 中间体 药物杂质

Product Data Sheet
Product Name:
CAS No.:
Cat. No.:
MWt:
Formula:
Purity :

Temozolomide85622-93-1HY-17364194.15C6H6N6O2>98%
Solubility:DMSO >20 mg/mL
Mechanisms:
Pathways:Cell Cycle/DNA Damage; Target:DNA alkylator/crosslinker
gyBiological Activity:
Temozolomide, an alkylating agent, is a DNA damage inducer.
IC50 Value:
Target: DNA alkylator
Temozolomide is a DNA methylating, chemotherapeutic agent. Temozolomide displays antitumoractivity against a board spectrum of tumors, including leukemias, lymphomas and solid tumors (IC50= 5.0 μM for cytotoxicity against mouse TLX5 lymphoma cells). Temozolomide induces autophagy inmalignant glioma cells. Temozolomide induces G2/M arrest and apoptosis through adduction of amethyl group to O6 position of guanine in genomic DNA and functional inactivation of DNA repairygppggpprotein O(6)-alkylguanine DNA alkyltransferase (AGT) in base excision repair (BER) pathway....References:
[1]. Plowman J, Waud WR, Koutsoukos AD et al. Preclinical antitumor activity of temozolomide inmice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res. 1994 Jul 15;54(14):3793-9.
[2]. Tentori L, Leonetti C, Scarsella M et al. Combined treatment with temozolomide and poly(ADP-[]py(ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at thecentral nervous system site. Blood. 2002 Mar 15;99(6):2241-4.
[3]. Günther W, Pawlak E, Damasceno R et al. Temozolomide induces apoptosis and senescence inglioma cells cultured as multicellular spheroids. Br J Cancer. 2003 Feb 10;88(3):463-9.
[4]. Beier D, R?hrl S, Pillai DR et al. Temozolomide preferentially depletes cancer stem cells inglioblastoma. Cancer Res. 2008 Jul 15;68(14):5706-15.
[5]. Johansson F, Ekman S, Blomquist...
Caution: Not fully tested. For research purposes only
Medchemexpress LLC
doc.guandang.net
18Wilkinson Way, Princeton, NJ 08540,USA
ess.com Web: doc.guandang.net

mEmail: info@medchemexpr
热门文档